Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
10.05
+0.35 (3.61%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Rapport Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Rapport Therapeutics stock have an average target of 37.33, with a low estimate of 35 and a high estimate of 42. The average target predicts an increase of 271.44% from the current stock price of 10.05.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 18, 2024.
Analyst Ratings
The average analyst rating for Rapport Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jones Trading | Jones Trading | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +317.91% | Oct 18, 2024 |
Stifel | Stifel | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +248.26% | Jul 2, 2024 |
TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jul 2, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +248.26% | Jul 2, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.64
from -3.78
EPS Next Year
-4.34
from -3.64
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | n/a | n/a |
Avg | n/a | n/a |
Low | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -3.41 | -3.01 | -3.05 |
Avg | -3.64 | -4.34 | -5.03 |
Low | -3.82 | -5.58 | -5.96 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.